Amenorrhoea

Lancet

Volumn 350, Issue 9073, 1997, Pages 275-279

  Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; PROLACTIN;

AMENORRHEA; ANOVULATION; FEMALE; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030759561     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06297-1     Document Type: Review

References (30)

1. Short RV The evolution of human reproduction. Proc R Soc Lond. 195:1976;3-24.
2. Baird DT. Amenorrhea, anovulation and dysfunctional uterine bleeding. In: De Groot LJ, ed. Endocrinology, 3rd edn. New York: WB Saunders, 1995: 2059-79.
3. Imperato-McGinley J. Male pseudohermaphroditism. In: Adashi EY, Rock JA, Rosenwalks Z, eds. Reproductive endocrinology, surgery and technology, vol 1. Philadelphia: Lippincott-Raven, 1995: 935-55.
4. Rock JA. Congenital outflow tract obstruction. In: Adashi EY,Rock JA, Rosenwalks Z, eds. Reproductive endocrinology, surgery and technology. Philadelphia: Lippincott-Raven, 1995: 1445-74.
5. Schenker JG, Margalioth E Intrauterine adhesions: an updated appraisal. Fertil Steril. 37:1992;593-610.
6. Kallmann F, Schonfield WA, Barrera SE The genetic aspects of primary eunuchoidism. Am J Mental Defic. 48:1994;203-236.
7. Schwanzel-Fukuda M, Bick D, Pfaff DN Luteinising-hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res. 6:1989;311-326.
8. Takeda T, Takasu N, Yamauchi Ket al. MRI imaging of the hypoplasia of the rhinencephalon in a patient with Kallmann's syndrome. Intern Med. 31:1992;394-396.
9. Ferin M, Jenelenicz R, Warren M. The menstrual cycle. New York: Oxford University Press, 1993.
10. Leyendecker G, Wildt L Induction of ovulation with chronic intermittent (pulsatile) administration of GnRH in women with hypothalamic amenorrhoea. J Reprod Fertil. 69:1983;397-409.
11. Taylor AE, Schneyer AL, Sluss PM, Crowley WF Jr. Ovarian failure, resistance and activation. In: Adashi EY, Leung PCK, eds. The ovary. New York: Raven Press, 1993: 629-61.
12. Wentz AC. Resistant ovary syndrome. In: Adashi EY, Rock JA, Rosenwalks Z, eds. Reproductive endocrinology, surgery and technology, vol 2. Philadelphia: Lippincott-Raven, 1995: 1385-92.
13. Huhtaniemi I, Pakarinen P, Nilsson C, Pettersson K, Tapanainen J, Aittomäki K. Polymorphisms and mutations of gonadotropin and gonadotropin receptor genes. In: Filicori M, Flamigni C, eds. The ovary: regulation, dysfunction and treatment. Amsterdam: Elsevier Science, 1996: 89-101.
14. Dong J, Albertini DF, Nishimori K, Kamur TR, Lu N, Matzu MM Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 383:1996;531-535.
15. Troche V, Hernandez E Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv. 41:1986;74-79.
16. Blackwell RE Hyperprolactinaemia: evaluation and management. Endocrinol Metab Clin North Am. 21:1992;105-125.
17. Ferrari C, Crosignani PG Medical treatment of hyperprolactinaemic disorders. Hum Reprod. 1:1986;507-514.
18. Laws ER Jr. Pituitary surgery. Endocrinol Metab Clin North Am. 16:1987;647-665.
19. Warren MP. Anorexia nervosa. In: de Groot LJ, ed. Endocrinology, 3rd edn. New York: WB Saunders, 1993: 2679-91.
20. Filicori M, Flamigni C, Meriggiola MLet al. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone induction in different disorders. J Clin Endocrinol Metab. 72:1991;965-972.
21. Van der Spuy ZM, Steer PJ, McCusker M, Steele SJ, Jacobs HS Outcome of pregnancy in underweight women after spontaneous and induced ovulation. BMJ. 296:1988;962-965.
22. Homburg R, Eshel E, Armar NAet al. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. BMJ. 298:1989;809-812.
23. Baird DT. Ovulation induction: current status and future prospects of gonadotropin therapy. In: Adashi EY, Leung PCK, eds. The ovary. New York: Raven, 1993: 529-44.
24. Loumaye E, Campbell R, Salat-Baroux J Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod Update. 1:1995;188-199.
25. Yen SSC The polycystic ovary syndrome. Clin Endocrinol. 12:1980;177-207.
26. Fox R, Corrigan E, Thomas PA, Hull MGR The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin Endocrinol. 34:1991;127-131.
27. Adams J, Polson DW, Franks S Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ. 293:1986;355-359.
28. Ferriman D, Purdie AW The inheritance of polycystic ovary disease and a possible relationship to premature balding. Clin Endocrinol. 11:1979;291.
29. Franks S Polycystic ovary syndrome. N Engl J Med. 333:1995;853-861.
30. Dunaif A Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin dependent diabetes mellitus. Am J Med. 98:1995;335-395.